- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
- 1-A/A Offering statement
- PART II AND III Part II and III
- EX1A-1 UNDR AGMT Form of Underwriting Agreement
- EX1A-3 HLDRS RTS Amendment to Second Amended and Restated Investors Rights Agreement
- EX1A-6 MAT CTRCT Omnibus Amendment to Convertible Promissory Notes by and Between the Company and Crosscart, LLC
- EX1A-6 MAT CTRCT 2015 Equity Incentive Plan
- EX1A-6 MAT CTRCT Form of Letter to Directors Regarding Deferred Fees
- EX1A-6 MAT CTRCT Form of Indemnification Agreement
- EX1A-6 MAT CTRCT Aperion Non-employee Director Compensation Program
- EX1A-8 ESCW AGMT Escrow Agreement
- EX1A-11 CONSENT Consent of Marcum LLP
- EX1A-12 OPN CNSL Opinion of Morgan, Lewis & Bockius LLP
- EX1A-13 TST WTRS Testing the Water Materials (Slide Deck)
- EX1A-13 TST WTRS Testing the Water Materials (WRC Website)
- EX1A-13 TST WTRS Testing the Water Materials (Crystal Summary)
- EX1A-13 TST WTRS Testing the Water Materials (Online Advertisement)
- EX1A-13 TST WTRS Testing the Water Materials (Tear Sheet)
- 21 Nov 16 1-A-W Offering statement withdrawal
- 19 Jan 16 1-A/A Offering $24.8M in Equity
- 17 Dec 15 1-A/A Offering $24.8M in Equity
- 16 Dec 15 1-A/A Offering $24.8M in Equity
- 15 Dec 15 1-A/A Offering $24.8M in Equity
- 14 Dec 15 1-A/A Offering $20M in Equity
- 24 Nov 15 1-A/A Offering $20M in Equity
-
10 Nov 15 1-A/A Offering $20M in Equity
- 23 Oct 15 1-A/A Offering $20M in Equity
- 22 Sep 15 1-A/A Offering in Equity
- 21 Sep 15 1-A Offering in Equity
Exhibit 11.1
Independent Registered Public Accounting Firm’s Consent
We consent to the inclusion in this Registration Statement of Aperion Biologics, Inc. on Form 1-A/A of our report dated September 21, 2015, except for Note 1A, as to which the date is November 9, 2015, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audit of the financial statements of Aperion Biologics, Inc. as of September 30, 2014 and 2013 and for the years ended September 30, 2014 and 2013, which report appears in the Offering Circular, which is part of this Offering Statement. We also consent to the reference to our Firm under the heading "Experts" in such Offering Circular.
/s/ Marcumllp
Marcumllp
New York, NY
November 10, 2015